Increased Expression of Vascular Endothelial Growth Factor (VEGF) in Castleman's Disease: Proposed Pathomechanism of Vascular Proliferation in the Affected Lymph Node

References

• Castleman B., Iverson L., Menendez V. P. Localized mediastinal lymphnode hyperplasia resembling thymoma. Cancer 1956; 9: 822–830
   PubMed Web of Science ®Google Scholar
• Keller A. R., Hochholzer L., Castleman B. Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer 1972; 29: 670–683
   PubMed Web of Science ®Google Scholar
• Flendrig J. A. Benign giant lymphoma: clinicopatho-logic correlation study. The Year Book of cancer, L. Rclark, W. Rcumley. Year Book Medical Publishers, Chicago 1970; 296–299
   Google Scholar
• Gaba A. R., Stein R. S., Sweet D. L., Variakojis D. Multicentric giant lymph node hyperplasia. American Journal of Clinical Pathology 1978; 69: 86–90
   PubMed Web of Science ®Google Scholar
• Weisenburger D. D., Nathwani B. N., Winberg C. D., Rappaport H. Multicentric angiofollicular lymph node hyperplasia: a clinicopathologic study of 16 cases. Human Pathology 1985; 16: 162–172
   PubMed Web of Science ®Google Scholar
• Herrada J., Cabanillas F. F. Multicentric Castle-man's disease. American Journal of Clinical Oncology 1995; 18: 180–183
   PubMed Web of Science ®Google Scholar
• Gherardi R. K., Malapert D., Degos J. D. Castleman disease-POEMS syndrome overlap. Annals of Internal Medicine 1991; 114: 520–521
   PubMed Web of Science ®Google Scholar
• Adelman H. M., Cacciatore M. L., Pascual J. F., Mike J. M., Alberts W. M., Wallach P. M. Case report: Castleman disease in association with POEMS. American Journal of the Medical Sciences. 1994; 307: 112–114
   PubMed Web of Science ®Google Scholar
• Nakanishi T., Sobue I., Toyokura Y., Nishitani H., Kuroiwa Y., Satoyoshi E., Tsubaki T., Igata A., Ozaki Y. The Crow-Fukase syndrome: a study of 102 cases in Japan. Neurology. 1984; 34: 712–720
   PubMed Web of Science ®Google Scholar
• Soubrier M. J., Dubost J. J., Sauvezie B. J. POEMS syndrome: a study of 25 cases and a review of the literature. American Journal of Medicine. 1994; 97: 543–553
   PubMed Web of Science ®Google Scholar
• Gherardi R. K., Belec L., Fromont G., Divine M., Malapert D., Gaulard P., Degos J. D. Elevated levels of interleukin-1 beta (IL-1 beta) and IL-6 in serum and increased production of IL-1 beta mRNA in lymph nodes of patients with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes (POEMS) syndrome. Blood 1994; 83: 2587–2593
   PubMed Web of Science ®Google Scholar
• Yoshizaki K., Matsuda T., Nishimoto N., Kuritani T., Taeho L., Aozasa K., Nakahata T., Kawai H., Tagoh H., Komori T., Kishimoto S., Hirano T., Kishimoto T. Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease. Blood 1989; 74: 1360–1367
   PubMed Web of Science ®Google Scholar
• Winter S. S., Howard T. A., Ritchey A. K., Keller F. G., Ware R. E. Elevated levels of tumor necrosis factor-beta, gamma-interferon, and IL-6 mRNA in Castleman's disease. Medical and Pediatric Oncology 1996; 26: 48–53
   PubMedGoogle Scholar
• Watanabe O., Arimura K., Kitajima I., Osame M., Maruyama I. Greatly raised vascular endothelial growth factor (VEGF) in POEMS syndrome. Lancet 1996; 347: 702
   PubMed Web of Science ®Google Scholar
• Soubrier M., Dubost J. J., Serre A. F., Ristori J. M., Sauvezie B., Cathebras P., Piette J. C., Chapman A., Authier F. J., Gherardi R. K. Growth factors in POEMS syndrome: evidence for a marked increase in circulating vascular endothelial growth factor. Arthritis & Rheumatism. 1997; 40: 786–787
   PubMed Web of Science ®Google Scholar
• Lesprit P., Godeau B., Authier F. J., Soubrier M., Zuber M., Larroche C., Viard J. P., Wechsler B., Gherardi R. Pulmonary hypertension in POEMS syndrome: a new feature mediated by cytokines. American Journal of Respiratory Critical Care Medicine. 1998; 157: 907–911
   PubMed Web of Science ®Google Scholar
• Watanabe O., Maruyama I., Arimura K., Kitajima I., Arimura H., Hanatani M., Matsuo K., Arisato T., Osame M. Overproduction of vascular endothelial growth factor (VEGF/VPF) is causative in POEMS syndrome. Muscle & Nerve. 1998; 21: 1390–1397
   PubMed Web of Science ®Google Scholar
• Foss H. D., Araujo I., Demel G., Klotzbach H., Hummel M., Stein H. Expression of vascular endothelial growth factor in lymphomas and Castleman's disease. Journal of Pathology 1997; 183: 44–50
   PubMed Web of Science ®Google Scholar
• Nishi J., Arimura K., Utsunomiya A., Yonezawa S., Kawakami K., Maeno N., Ijichi O., Ikarimoto N., Nakata M., Kitajima I., Fukushige T., Takamatsu H., Miyata K., Maruyama I. Expression of vascular endothelial growth factor in sera and lymph nodes of the plasma cell type of Castleman's disease. British Journal of Haematology. 1999; 104: 482–5
   PubMed Web of Science ®Google Scholar
• Maeno N., Takei S., Imanaka H., Takasaki I., Kitajima I., Maruyama I., Matsuo K., Miyata K. Increased circulating vascular endothelial growth factor is correlated with disease activity in polyarticular juvenile rheumatoid arthritis. Journal of rhematology, (in press)
   Web of Science ®Google Scholar
• Hanatani M., Tanaka Y., Kondo S., Ohmori I., Suzuki H. Sensitive chemiluminescence enzyme immunoassay for vascular endothelial growth factor/vascular permeability factor in human serum. Bioscience Biotechnology and Biochemistry 1995; 59: 1958–1959
   PubMed Web of Science ®Google Scholar
• Keyt B. A., Berleau L. T., Nguyen H. V., Chen H., Heinsohn H., Vandlen R., Ferrara N. The carboxyl-terminal domain (111–165) of vascular endothelial growth factor is critical for its mitogenic potency. Journal of Biological Chemistry., 271: 7788–7795
   PubMed Web of Science ®Google Scholar
• Soker S., Takashima S., Miao H. Q., Neufeld G., Klagsbrun M. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell., 92: 735–745
   PubMed Web of Science ®Google Scholar
• Mandler R. N., Kerrigan D. P., Smart J., Kuis W., Villiger P., Lotz M. Castleman's disease in POEMS syndrome with elevated interleukin-6. Cancer 1992; 69: 2697–2703
   PubMed Web of Science ®Google Scholar
• Ishiyama T., Nakamura S., Akimoto Y, Koike M., Tomoyasu S., Tsuruoka N., Murata Y., Sato T., Wakabayashi Y., Chiba S. Immunodeficiency and IL-6 production by peripheral blood monocytes in multicentric Castleman's disease. British Journal of Haematology. 1994; 86: 483–489
   PubMed Web of Science ®Google Scholar
• Cohen T., Nahari D., Cerem L. W., Neufeld G., Levi B. Z. Interleukin 6 induces the expression of vascular endothelial growth factor. Journal of Biological Chemistry 1996; 271: 736–741
   PubMed Web of Science ®Google Scholar
• Soulier J., Grollet L., Oksenhendler E., Cacoub P., Cazals-Hatem D., Babinet P., D'Agay M. F., Clauvel J. P., Raphael M., Degos L., Francois S. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood. 1995; 86: 1276–1280
   PubMed Web of Science ®Google Scholar
• Chang Y., Cesarman E., Pessin M. S., Lee F., Culpepper J., Knowles D. M., Moore P. S. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994; 266: 1865–1869
   PubMed Web of Science ®Google Scholar
• Ganem D. KSHV and Kaposi's sarcoma: the end of the beginning. Cell. 1997; 91: 157–160
   PubMed Web of Science ®Google Scholar
• Cesarman E., Chang Y., Moore P. S., Said J. W., Knowles D. M. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. New England Journal of Medicine. 1995; 332: 1186–1191
   PubMed Web of Science ®Google Scholar
• Belec L., Mohamed A. S., Authier F. J., Hallouin M. C., Soe A. M., Cotigny S., Gaulard P., Gherardi R. K. Human herpesvirus 8 infection in patients with POEMS syndrome-associated multicentric Castleman's disease. Blood. 1999; 93: 3643–3653
   PubMed Web of Science ®Google Scholar
• Oksenhendler E., Duarte M., Soulier J., Cacoub P., Welker Y., Cadranel J., Cazals-Hatem D., Autran B., Clauvel J. P., Raphael M. Multicentric Castleman's disease in HIV infection: a clinical and pathological study of 20 patients. AIDS. 1996; 10: 61–67
   PubMed Web of Science ®Google Scholar
• Gessain A., Sudaka A., Briere J., Fouchard N., Nicola M. A., Rio B., Arborio M., Troussard X., Audouin J., Diebold I. Kaposi sarcoma-associated herpes-like virus (human herpesvirus type 8) DNA sequences in multicentric Castleman's disease: is there any relevant association in non-human immunodeficiency virus-infected patients. Blood. 1996; 87: 414–416
   PubMed Web of Science ®Google Scholar
• Barozzi P., Luppi M., Masini L., Marasca R., Savarino M., Morselli M., Ferrari M. G., Bevini M., Bonacorsi G., Torelli G. Lymphotropic herpes virus (EBV, HHV-6, HHV-8) DNA sequences in HIV negative Castleman's disease. Journal of Clinical pathology. 1996; 49: M232–M235
   Web of Science ®Google Scholar
• Kikuta H., Itakura O., Taneichi K., Kohno M. Tropism of human herpesvirus 8 for peripheral blood lymphocytes in patients with Castleman's disease. British Journal of Haematology. 1997; 99: 790–793
   PubMed Web of Science ®Google Scholar
• Moore P. S., Boshoff C., Weiss R. A., Chang Y. Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science 1996; 274: 1739–1744
   PubMed Web of Science ®Google Scholar
• Parravicini C., Corbellino M., Paulli M., Magrini U., Lazzarino M., Moore P. S., Chang Y. Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease. American Journal of Pathology 1997; 151: 1517–1522
   PubMed Web of Science ®Google Scholar
• Aoki Y., Jaffe E. S., Chang Y., Jones K., Teruya-Feldstein J., Moore P. S., Tosato G. Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6. Blood. 1999; 93: 4034–4043
   PubMed Web of Science ®Google Scholar
• Bowne W. B., Lewis J. J., Filippa D. A., Niesvizky R., Brooks A. D., Burt M. E., Brennan M. F. The management of unicentric and multicentric Castleman's disease: a report of 16 cases and a review of the literature. Cancer. 1999; 85: 706–717
   PubMed Web of Science ®Google Scholar
• Beck J. T., Hsu S. M., Wijdenes J., Bataille R., Klein B., Vesole D., Hayden K., Jagannath S., Barlogie B. Brief report: alleviation of systemic manifestations of Castleman's disease by monoclonal anti-interleukin-6 antibody. New England Journal of Medicine. 1994; 330: 602–605
   PubMed Web of Science ®Google Scholar
• Tamayo M., Gonzalez C., Majado M. J., Candel R., Ramos J. Long-term complete remission after interferon treatment in a case of multicentric Castleman's disease. American Journal of Hematology, 49: 359–360
   PubMed Web of Science ®Google Scholar